Saintil Merline has demonstrated a consistent pattern of selling activity across four companies—Rocket Lab (RKLB), Symbotic (SYM), TD Synnex (SNX), and GitLab (GTLB)—with no recorded purchases in the available SEC filings. The bulk of the selling occurred in Rocket Lab, where Merline executed multiple high-value transactions between December 2025 and March 2026, including a $8.31 million sale on January 13, 2026, and a $1.36 million sale on March 6, 2026. Smaller but repeated sales in Symbotic, such as $324,105 and $316,134 on November 28, 2025, and $158,059 on March 11, 2026, further underscore the sell-side bias. TD Synnex and GitLab saw comparatively modest activity, with sales in the tens of thousands, such as $52,345 in SNX on November 3, 2025, and $27,619 in GTLB on July 2, 2025.
The absence of buy transactions suggests Merline has been steadily reducing exposure, particularly in Rocket Lab, which accounted for the majority of the $13.94 million in total sales. Recent filings show continued disposals, including a $15,425 SYM sale on March 11, 2026, reinforcing the trend. While some filings for SYM and RKLB include acquisition or merger-related codes (A/M) with no reported value, the overall activity remains overwhelmingly weighted toward divestment. The pattern does not indicate accumulation in any of the four holdings, instead reflecting a prolonged unwind across multiple positions.
AI-assisted summary